Acknowledgement to Referees.
- Published in:
- BioDrugs, 2019, v. 33, n. 6, p. 595, doi. 10.1007/s40259-019-00397-8
- Publication type:
- Article
Works matching IS 11738804 AND DT 2019 AND VI 33 AND IP 6
Results: 11
1
2
Biosimilars: An Opportunity to Update the Product Information of Biological Drugs Regarding their Immunogenicity.
- Published in:
- 2019
- By:
- Publication type:
- Letter
3
Delivering on the Promise of Biosimilars.
- Published in:
- 2019
- By:
- Publication type:
- Letter
4
Analysis of Immunogenicity Data in the Product Information of Biological Drugs: A Need to Report Immunogenicity Data Systematically.
- Published in:
- BioDrugs, 2019, v. 33, n. 6, p. 683, doi. 10.1007/s40259-019-00387-w
- By:
- Publication type:
- Article
5
CAR-T Engineering: Optimizing Signal Transduction and Effector Mechanisms.
- Published in:
- BioDrugs, 2019, v. 33, n. 6, p. 647, doi. 10.1007/s40259-019-00384-z
- By:
- Publication type:
- Article
6
Different Cardiotoxicity of Palbociclib and Ribociclib in Breast Cancer: Gene Expression and Pharmacological Data Analyses, Biological Basis, and Therapeutic Implications.
- Published in:
- BioDrugs, 2019, v. 33, n. 6, p. 613, doi. 10.1007/s40259-019-00382-1
- By:
- Publication type:
- Article
7
Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar.
- Published in:
- BioDrugs, 2019, v. 33, n. 6, p. 661, doi. 10.1007/s40259-019-00381-2
- By:
- Publication type:
- Article
8
Steady-State Plasma Concentrations of Polyethylene Glycol (PEG) are Reached in Children and Adults During Once-Weekly Prophylactic Treatment with Nonacog Beta Pegol (N9-GP).
- Published in:
- BioDrugs, 2019, v. 33, n. 6, p. 673, doi. 10.1007/s40259-019-00380-3
- By:
- Publication type:
- Article
9
Evolution of the EU Biosimilar Framework: Past and Future.
- Published in:
- BioDrugs, 2019, v. 33, n. 6, p. 621, doi. 10.1007/s40259-019-00377-y
- By:
- Publication type:
- Article
10
Extrapolation in Practice: Lessons from 10 Years with Biosimilar Filgrastim.
- Published in:
- BioDrugs, 2019, v. 33, n. 6, p. 635, doi. 10.1007/s40259-019-00373-2
- By:
- Publication type:
- Article
11
An Efficient Development Paradigm for Biosimilars.
- Published in:
- BioDrugs, 2019, v. 33, n. 6, p. 603, doi. 10.1007/s40259-019-00371-4
- By:
- Publication type:
- Article